NCT00316563: Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study |
|
|
| Completed | 2 | 80 | Canada | Marinol (Dronabinol), Placebo | Alberta Health services, University of Alberta | Cancer, Anorexia, Taste Disorders, Olfactory Disorders | | 11/09 | | |
